Introduction
One of the most efficient and widespread mechanisms of cell or microbial resistance to cytotoxic drugs and antibiotics is mediated through the action of efflux transporters. Such transporters fall into two broad, mechanistically, functionally and evolutionary, distinct protein families, the so-called ABC and MFS (Wong et al., 2014; Prasad and Rawal, 2014; Paul and Moye-Rowley, 2014) . ABC (ATP-Binding Cassette) transporters utilize ATP hydrolysis to drive the efflux of cytotoxic compounds out of cells and are usually very promiscuous in respect to substrate specificity (Theodoulou and Kerr, 2015; Beis, 2015; Hong, 2016) . Current evidence supports that ABC transporters capture their, usually, hydrophobic substrates within the plasma membrane, when these are slowly diffusing across the lipid bilayer. In contrast, MFS (Major Facilitator Superfamily) transporters mediate the efflux of drugs or antibiotics using the plasma membrane electrical potential (antiport or symport mechanisms) or via a facilitation mechanism (uniport), rather than ATP hydrolysis and, generally, are more substrate specific, compared to ABCs (Kaback 2015; Zhang et al., 2015; Quistgaard et al., 2016) . In their case, toxic substrates accumulated cytoplasmically bind from the inner side of the plasma membrane to a single binding site located in the middle of the transporter, promoting a rocker-switch type of movement of the two halves of the protein body, which exposes and releases the drug outside the cell (alternating-access mechanism). In other words, MFS efflux transporters function with the same basic mechanism that the majority of MFS members also employ for importing solutes, nutrients or some drugs, but in the opposite direction.
The MFS family is the largest transporter group that includes over 10,000 sequenced members (Yan, 2015; Saier et al., 2016) . Both prokaryotic and eukaryotic cells possess a great number of MFSs, higher fungi and especially ascomycetes being the champions with more than 8% of their genes encoding putative MFS proteins (Diallinas, 2008) . Although a significant number of MFSs have been functionally characterized, in both prokaryotes and eukaryotes, and several have also been crystallized and analyzed with respect to structure-function relationships (http://blanco.biomol.uci.edu/mpstruc/), the majority of them in all organisms remain uncharacterized. Importantly, there is no way to predict the specificity of functionally uncharacterized MFSs by simply comparing protein sequences, due to extensive divergence, but also repeated convergent evolution phenomena. Additionally, we can neither predict whether an MFS is acting as an importer or an exporter of a solute or drug. Only in cases where an MFS gene is clustered together with genes encoding enzymes of known metabolic pathways, predictions can be made. Indeed, many fungal secondary metabolite clusters contain putative MFS transporters (and more rarely ABC transporters), which might mediate the export of relevant secondary metabolites. Some clustered fungal transporters have been deleted and the resulting null mutants characterized in respect to relevant metabolite secretion. The results are however inconsistent: some transporter deletions show no phenotype (e.g. aflatoxin), some do not impact production, but afford self-protection towards the endogenous metabolite (e.g. sirodesmin and gliotoxin), whereas others are required for product formation (e.g. zearalenone). Thus the presence of a clustered transporter does not necessarily reveal its function and specificity (Chang et al., 2004; Hidalgo et al., 2014; Lim et al., 2014; Brown et al., 2015) . Specifically for the present work, no MFS transporter has ever been related to the efflux of cadmium and/or zinc (http://www.tcdb. org/; see later).
Transposon mutagenesis is a powerful tool for the genetic analysis of novel functions and genome mining, especially under the light of the growing number of microbial genomes that continuously become available (Miskey et al., 2005; Muñoz-L opez and Garc ıa-P erez, 2010) . While rational reverse genetic approaches for protein functional analysis concern the generation of knock-outs, transposon-based analysis is based on the generation of mutant phenotypes, which allows the identification of genes through their hyper-expression (hypermorphs) or down-regulation of expression (hypomorphs), rather than complete knock-out. Recently, we developed an efficient novel transposon mutagenesis approach, based on the Minos element of Drosophila hydeii (Pavlopoulos et al., 2007) that allowed us to obtain morphological or drugresistant mutants in the model filamentous fungus Aspergillus nidulans (Evangelinos et al., 2015) . In our screens using AnMinos, we obtained evidence that a number of morphological mutants isolated were due to hyperexpression of genes located next to transposon insertions. Additionally, among several 5-fluorouracil resistant mutants selected, three insertions of AnMinos were localized in the 5 0 upstream region of an uncharacterized gene (AN2746) encoding a putative MFS transporter.
In this work, we define the nature of these transposon insertions and show that they all lead to relevant activation of transcription of AN2746. Subsequently, we investigate further the functional role of the AN2746 gene product, called NmeA, and obtain evidence that it functions as an efflux transporter specific for cytotoxic purine-related metabolites and metals or metalloids. This is the first description of an MFS transporter with the above function and specificity. Finally, we discuss how resistance to metals might be related to purine catabolism.
Results
NmeA is an MFS transporter involved in toxic nucleobase/nucleoside analogue resistance
We have previously isolated three A. nidulans mutants (Fur-1, 22 and 23) resistant to 5-FU arising from three distinct transpositions of the AnMinos transposable elements in the 5' upstream region of the functionally uncharacterized gene AN2746 (Evangelinos et al., 2015; Supporting Information Fig. S1, upper panel) . The fact that three independent and different transposition events led to the same phenotype established a causal link between the transposon insertion and the resistance to the toxic analogues. All three mutants were also shown to be resistant to 5-FC and 5-FUd (Supporting Information Fig. S1 , lower panel). Fur-1, which was significantly closer to the predicted translation start of AN2746 (-264 nt) conferred relatively the strongest resistance to the fluorinated nucleobase/nucleoside analogues (Fur-1 > Fur-2 or Fur-3). In silico sequence analysis of the AN2746 open reading frame (ORF) showed that it encodes for a putative MFS transporter that exhibits low sequence similarity with putative members of a monocarboxylate transporter family (MCTs) (Evangelinos et al., 2015) .
The simplest explanation on how the above AnMinos transposon insertions led to toxic nucleobase/nucleoside analogue resistance is that they either knock-down the transcription of a relative transporter mediating the uptake of these toxic compounds, or that the transposon insertions led to the transcriptional activation of a cryptic efflux protein that is specific for nucleobase/nucleoside analogues. However, the first hypothesis, although mechanistically sound, was not supported by previous data from our lab showing that the uptake of 5-FU, 5-FC or 5-FUd is mediated by well-studied transporters of the Fur, Fcy and Cnt families, respectively, none of which includes the putative AN2746 transporter, and none of which is related to MFS transporters (Pantazopoulou and Diallinas, 2007; Krypotou et al., 2015b; Sioupouli et al., 2017) . Thus, the most probable scenario was that AN2746 is an efflux transporter capable of recognizing and exporting nucleobases/nucleosides. In this work, we subsequently show this is indeed the case.
We performed comparative protein sequence and phylogenetic analyses of the putative transporter encoded by AN2746, hereafter named NmeA (Nucleobase/Nucleoside Metal Efflux transporter A). Supporting Information Fig. S2 shows that NmeA is absolutely conserved in all Aspergilli, with all orthologues presenting sequence identities close to 66-85% and conserved intron positions (not shown). Probable true orthologues were also found in other Eurotiomycetes (e.g. Penicillium with 69% identity, Talaromyces with 60% identity or Coccidioides with 53% identity), but not in other fungal groups or in non-fungal organisms. NmeA shows low similarity with MFS members present in all domains of life, including the two main MFS sub-families specifically related to efflux of drugs, metals and other cytotoxic metabolites (DHA1 and DHA2) (Nelissen et al., 1997) , but the relevant sequence identity is not sufficient for allowing predictions on its function or specificity. Noticeably however, Fig. 1 shows that among the top scores of NmeA similarity (>32.0-44.1%) with other A. nidulans MFS transporters, most correspond to transporters of unknown function, but 3 are considered as putative efflux transporters (for more details see legend of Fig. 1 ). Other functionally characterized A. nidulans MFS associated to solute uptake (e.g. xylose or glucose) show weaker similarities with NmeA (<29% identity). Overall, our data suggested that NmeA is novel efflux transporter capable of exporting toxic nucleobase/ nucleoside analogues. Finally, NmeA is predicted, using several in silico tools, to have 12 putative transmembrane segments (TMSs) and cytoplasmic N-or Cterminal regions of 30-43 amino acids (see also alter).
nmeA is a very low-transcribed gene under standard laboratory conditions
Given that all evidence suggested that transposonmediated activation of nmeA expression in the Fur-1, 22 and 23 mutants leads to resistance to toxic nucleobase/nucleoside analogues, we reasoned that nmeA might be little transcribed under standard growth conditions in a wild-type genetic background. A search in the available data from transcriptomic analyses has indeed showed that nmeA is transcribed at very low levels under all conditions tested. We performed a northern blot analysis of total RNA extracted from mycelia of the Fur-1 and Fur-2 mutants and its isogenic wild-type background (AnMinos yA -). Figure 2A confirms our prediction To formally show that increased nmeA transcription leads to toxic nucleobase/nucleoside analogue resistance, we constructed a strain over-expressing nmeA via the strong gpdA promoter (gpdA p -nmeA) (Fig. 2B , see also later in Fig. 4C ), as well as, a strain with a total deletion of the nmeA orf (nmeAD) [For details of strains construction see Experimental procedures]. These strains and isogenic controls were tested by resistance/ sensitivity growth tests related to several toxic metabolites, drugs, oxidizing agents or metals. The gpdA p -nmeA strain showed significant resistance to 5-FUd, 5-FC, 5-FU, oxypurinol and less so to 8-azaguanine (Fig. 3A) . Surprisingly, NmeA overexpression also led to increased cadmium, zinc or boron (borate) tolerance when compared to wild-type strains (Fig. 3B) . Contrastingly, the gpdA p -nmeA strain showed a sensitive phenotype, similar to wild-type, on itraconazole, Hygromycin D, acetic acid, propionic acid, 3-bromopyruvate, amino acid toxic analogues (D-serine and p-fluorophenylalanine), spermidine, spermine, putrescine, hydrogen peroxide, methylene blue, ethanol A. Northern blot analysis of nmeA steady state mRNA levels in strains carrying the transposon element AnMinos (Evangelinos et al., 2015) . AnMinos yA -stands for the original strain carrying the AnMinos integrated in the niaD genomic locus, whereas Fur-1 and Fur-2 correspond to isogenic strains with transposition events of AnMinos in the 5' upstream region of nmeA, as shown in Supporting Information Figure S1 . B. Northern blot analysis of nmeA steady state mRNA levels in strains overexpressing nmeA, via the gpdA p promoter, as compared to nmeA expression from its native endogenous promoter. The gpdA p -nmeA panel is exposed for 2 days to minimize saturation, while the wild-type control strain was exposed for 5 days. Thus, gpdA p -driven transcription of nmeA is estimated to be approx. 50-fold of that obtained with the native promoter. For both (A) and (B), steady-state mRNA levels of nmeA are detected using a nmeA-specific radiolabeled probe. In all cases, total RNA is extracted from strains grown for 18 h in MM plus sodium nitrate and necessary supplements. Equal loading of total RNA in each lane is depicted by the amount of 16S rRNA.
Fig. 3.
NmeA expression is directly related to resistance/sensitivity to nucleobase or nucleoside toxic analogues (A) and cadmium, zinc or boron (B), in relative growth test. gpdA p -nmeA is the strain overexpressing nmeA and nmeAD is a null mutant of nmeA. Wt stands for a standard wild-type strain expressing nmeA by its endogenous promoter. D7 is a control strain which genetically lacks the 7 main transporters of purines, pyrimidines, nucleosides and allantoin, so it appears to be resistant to all the toxic nucleobase/ nucleoside analogues shown. Growth tests are performed on minimal-glucose media (MM), supplemented with 10 mM sodium nitrate as sole nitrogen source, plus the necessary vitamins, at 378C for 2-3 days. 5-FU, 5-FC, 5-FUd, 8-AzaG, Oxyp stand for 5-fluorouracil, 5-fluorocytosine, 5-fluorouridine, 8-azaguanine and oxypurinol, respectively. Concentrations of analogues and other toxic compounds are described in Experimental procedures.
and copper (not shown). Importantly, the nmeAD knockout strain showed increased sensitivity to 5-FUd, 5-FC, 5-FU, oxypurinol and 8-azaguanine (Fig. 3A) , but, also, to cadmium, zinc and borate ( Fig. 3B ), which is in fact a mirror-image phenotype compared to the one obtained with the strain overexpressing NmeA (gpdA p -nmeA). These growth tests confirmed that overexpression of nmeA is the causative mechanism for nucleobaserelated drug or specific metal resistance.
NmeA is a plasma membrane transporter
We constructed a strain expressing a GFP-tagged NmeA protein from its endogenous promoter in an effort to detect its subcellular localization and possible cellular regulation (see Experimental procedures). Unfortunately, we could not detect any fluorescence signal of the chimeric protein (not shown). This is most probably due to the very low transcription of the gene, but might also be due to transporter instability caused by the GFP tag. We proceeded by constructing a strain expressing NmeA-GFP from the gpdA p promoter, which allowed us to confirm that NmeA is a plasma membrane protein. Figure 4A shows the in vivo epifluorescence analysis of gpdA p -nmeA-gfp, depicting strong and rather stable fluorescent signal associated with the plasma membrane in young mycelia, as expected for a plasma membrane protein. This signal is not affected by addition of tentative substrates of NmeA, such as uracil or 5-fluorouracil, or the addition of a rich nitrogen source such as ammonium (results not shown), as often is the case for solute importers (Gournas et al., 2010) . Importantly, the NmeA-GFP chimeric protein is still able to detoxify A. nidulans from toxic nucleobases/nucleosides or metals, confirming that the GFP-tagged NmeA version is functional so that its subcellular localization detected is the physiological one ( Fig. 4B and results not shown). The over-expression of a stable NmeA-GFP chimeric protein was further conformed using relevant western blot analysis with anti-GFP oligoclonal antibody (Fig. 4C ). To our knowledge, NmeA is the first plasma membrane MFStype efflux transporter capable of detoxifying cells form toxic purine/pyrimidine-related analogues and metals.
NmeA confers resistance to metabolically accumulated uric acid and allantoin
One basic question to answer was whether NmeA recognizes as substrates and exports natural nucleobases or nucleosides, in addition to their toxic analogues. To test this idea, we made use of genetic blocks in purine catabolism or in purine/pyrimidine biosynthesis (Supporting Information Fig. S3 ). The rationale behind this genetic approach was the following. In the first case, genetic lesions in catabolic genes result in increased accumulation of metabolic intermediates, which in the case of null mutations in uaZ (uric acid oxidase) or alX (allantoinase) result in toxic accumulation of uric acid or allantoin, respectively, when cells are grown in purinecontaining media. Thus, if NmeA effluxes uric acid or allantoin it might rescue cells from the cytotoxic effects of these intermediate products of purine catabolism. A. In vivo epifluorescence analysis of a strain expressing NmeA-GFP from the gpdA p promoter, depicting a strong fluorescent signal associated with the plasma membrane in young mycelia. For details concerning the growth of the strain, see Experimental procedures. B. Growth testing confirms that the NmeA-GFP fusion protein is functional as it confers strong resistance to 5-FUd, when expressed via the gpdA p promoter, similar to what is observed with the untagged NmeA. The colonies shown are yellow because the NmeA-GFP construct is expressed, for technical reasons, in a strain carrying the yA2 mutation affecting a laccase responsible for conidiospore color. C. Western blot analysis, using an anti-GFP antibody, confirming the hyper-expression of NmeA, when transcribed from the gpdA promoter. The expression of the actin protein is used as an internal control in the lower panel.
Additionally, genetic blocks in purine or pyrimidine biosynthesis, such as adH (phosphoribosyl-formyl-glycinamide synthase) or pyrG (orotidine-5 0 -phosphate decarboxylase), lead to relevant auxotrophies, which are rescued by supplying of adenine or uracil, respectively, from the growth medium. If NmeA effluxes these tentative substrates it might compromise the rescuing effect of externally provided adenine or uracil by reducing their steady state accumulation within cells, especially when these are supplied at low concentrations. To test the above ideas, we introduced gpdA p -nmeA in uaZ14, alXD, adH23 or pyrG89 loss-of function mutants (See Supporting Information Table S1 ), by standard genetic transformation or genetic crossing (see Experimental procedures) and tested selected transformants in purine-or pyrimidine-supplied media. Figure 5A shows that overexpression of NmeA rescues the uaZ14 mutant from uric acid toxicity, and also reduces allantoin toxicity in the alXD mutant. As uric acid or allantoin are known not to be converted in any other metabolite in uaZ and alX null mutants, respectively, but instead accumulate in the cytoplasm at toxic relatively high concentrations (>200-500 lM), we conclude that NmeA specifically recognizes and effluxes these compounds. On the other hand, Fig. 5B shows that NmeA overexpression did not affect significantly the sub-supplementation of adH23 or pyrG89 auxotrophies by addition of external adenine or uracil, respectively, although some reduction in growth was detectable in the strains expressing gpdA p -nmeA. However, adenine and uracil are salvageable nucleobases, which are rapidly metabolized, so that their cytoplasmic levels remain always extremely basal (< 5 lM). Thus, we cannot exclude that adenine and uracil might also be potential NmeA substrates, which are however not recognized due to their low cellular concentration level and a relatively low affinity of NmeA for them.
Direct evidence that NmeA effluxes uric acid and allantoin
NmeA was shown to confer resistance to metabolically accumulated uric acid and allantoin in uaZ14 or alXD strains, respectively (see Fig. 5A ). To obtain direct evidence that NmeA effluxes metabolically accumulated uric acid or allantoin in these strains, we employed HPLC measurements of these metabolites in the supernatant of adenine-grown (adenine 1 mM for 16 h) cultures of isogenic wild-type, uaz14 or alXD strains, expressing NmeA either from its endogenous promoter or from the gpdA p promoter or carrying a total deletion of the nmeA gene (for HPLC details see Experimental procedures). Results are summarized in Table 1 . In a wild-type background, where uric acid and allantoin are rapidly catabolized to urea and ammonium, we could not detect significant amounts of these metabolites in the supernatant. In contrast, a dramatic NmeA- Fig. 5 . nmeA overexpression confers resistance to metabolically accumulated uric acid and allantoin, but has no effect on supplementation of uracil or adenine auxotrophic mutants. A. Growth tests on MM containing uric acid (UA) or allantoin (All) of strains over-expressing nmeA (gpdA p -nmeA) in genetic backgrounds blocked in purine catabolism due to loss-of-function mutations in uric acid oxidase (uaz14) or allantoinase (alxD). Isogenic uaZ14 or alxD, which do not overexpress nmeA, and a wild-type (wt) strain are also shown. Control media are standard MM with nitrate as a nitrogen source. B. Growth tests, on nitrate-containing media supplemented with different restrictive concentrations of uracil or adenine of strains overexpressing nmeA (gpdA p -nmeA) in genetic backgrounds blocked in uracil (pyrG89) or adenine (adH23) biosynthesis. Isogenic strains pyrG89 or adH23 that do not overexpress nmeA strain and a wt control are also shown. Nucleobase and metal efflux transporter 431 dependent increase in uric acid accumulation was detected in the uaZ14 strain (145-240 lg ml 21 ). Noticeably, the uaZ14 nmeAD strain also shows a relative increase in uric acid excretion, when compared to wild-type strains, but this is $4-to 7-fold lower that in the increase in strains expressing a functional NmeA. This observation suggests that there might be a secondary uric acid efflux transporter remaining in nmeAD strains. Lastly, although we could not detect an NmeAdependent increase in allantoin in the alXD gpdA pNmeA mutant, as might be expected given the result of the growth tests shown in Fig. 5A , we did detect a prominent increase of an unknown, but with allantoinsimilar absorbance, metabolite. HPLC evidence suggests that this metabolite corresponds to allantoic acid, the immediate oxidation product of allantoin (results not shown). Thus, NmeA seems to also efflux allantoin, which is subsequently oxidized to allantoic acid in the supernatant.
NmeA also leads to reduced accumulation, apparently via increased efflux, of xanthine and adenine
To address further the substrate specificity profile of NmeA-mediated efflux, we used a double xanAD hxA18 mutant background, which blocks purine catabolism at different enzymatic step, leading to hypoxanthine or xanthine accumulation (see Supporting Information Fig.  S3 ). hxA18 is a total loss-of-function mutation (an early stop codon) in purine hydroxylase I, the major enzyme catalyzing the two-step conversion of hypoxanthine to xanthine and xanthine to uric acid. xanAD is a null deletion mutation of xanthine dioxygenase, an enzyme of an alternative minor pathway converting xanthine to uric acid. Thus, a xanAD hxA18 double mutant supplied with adenine or hypoxanthine accumulates mostly hypoxanthine, and some xanthine due to the low activity of HxnS, a low capacity purine hydroxylase (Galanopoulou et al., 2014) . This is reflected in growth tests where xanAD hxA18 does not grow at all on adenine, hypoxanthine or xanthine, as these cannot be catabolized, but grows normally on uric acid or allantoin (Galanopoulou et al., 2014) . We performed uptakes and efflux assays in isogenic xanAD hxA18 and gpdA p -NmeA xanAD hxA18 measuring radiolabeled adenine or xanthine accumulation or efflux (Fig. 6) . We obtained evidence that adenine or xanthine accumulation, measured after a period of 30 min, is reduced to 78% and 46%, respectively, in the strain over-expressing NmeA compared to that the strain expressing NmeA from its weak endogenous promoter. This result strongly suggested that NmeA might counteract accumulation via efflux, operating in parallel with influx. More importantly, we obtained direct evidence that NmeA leads to efflux of accumulated adenine or xanthine, by measuring the levels of radiolabeled substrates remaining within 'washed' cells, after a 30 min period of incubation in media without purines (see Materials and methods for details). In the xanAD hxA18 strain, washed cells conserved radiolabeled substrates at levels close to originally accumulated levels (98% for adenine or 85% for xanthine). Contrastingly, the strain over-expressing NmeA in the same background conserved significantly lower levels of the originally accumulated amounts of adenine (71%) or xanthine (66%). These results (Fig. 6 ) confirm that NmeA can also efflux adenine and xanthine, given that these are over-accumulated due to metabolic lesions.
Noticeably, the presence of a functional NmeA transporter did not affect the initial uptake rate of radiolabeled adenine, xanthine or uracil in strains that normally metabolize purines (Supporting Information Fig. S4 ). Unfortunately, we could not test radiolabeled uric acid (unstable) or allantoin (commercially not available) for technical reasons. Most probably, externally supplied Fig. 6 . NmeA overexpression leads to reduced accumulation via increased efflux of xanthine and adenine. Two isogenic strains blocked in the catabolism of hypoxanthine and xanthine due to total loss-of-function mutations xanAD and hxA18 in the genes coding for purine hydroxylase I and xanthine oxidase, respectively (see Supporting Information Fig. S3 ), differing solely in the level of expression of NmeA, were used to measure the accumulation of radiolabeled xanthine or adenine after a period of 30 min uptake or 30 min uptake followed by 30 min efflux from washed cells (for details see materials and methods). Radiolabeled adenine or xanthine was used at 100 lM. Notice that the strain overexpressing NmeA (xanAD hxA18 gpdAp-nmeA) accumulates lower amounts of adenine (78.2%) and xanthine (46.1%), compared to the isogenic xanAD hxA18 strain, which expresses NmeA at very low levels. Notice also that the xanAD hxA18 strain, after 30 min of potential efflux, conserves 98.0% and 85.1% of pre-accumulated radiolabeled adenine or xanthine, whereas the strain overexpressing NmeA (xanAD hxA18 gpdAp-nmeA) conserves lower levels, that is, 70.8% adenine and 65.9% of xanthine. The results shown represent an average of three experiments with SD < 10%. natural purines or pyrimidines are not recognized by NmeA when these are rapidly metabolized so that their steady state cytoplasmic accumulation remains constantly low.
Thus, all evidence obtained so far strongly suggest that NmeA effluxes nucleobase-related metabolites only when these are cytoplasmically accumulated at concentrations that are toxic to the fungus.
Structural modeling identifies a putative substrate binding site in NmeA
Docking calculations of uric acid and 5-fluorouridine inside the NmeA transporter pore were performed by implementing a flexible semi-stochastic sampling algorithm and a diverse set of low energy poses were obtained. A large sampling window in terms of ligand translational motion was utilized, facilitating extensive conformational space coverage. Calculations afforded a number of binding modes that outlined a possible pathway for the translocation of the substrates along the pore axis. Several residues of putative importance for substrate recognition and translocation were identified as part of the interface between the pore and the channel (Fig. 7A) . Such residues were considered important for substrate binding on the basis of their sidechain content, given that the most frequent interactions in a translocation event are accommodated by polar residues, facilitating anchoring of substrates through hydrogen bonds of medium strength, and by aromatic residues, offering weak interactions via p-p-stacking (Soares-Silva et al., 2011; Kosti et al., 2012) . More specifically, residues with a polar or aromatic sidechain, such as Asn65, Trp67 (in TMS1), Gln94 (TMS2), Gln145, Phe157 (TMS4), Ser183, Ser184, Tyr190 (TMS5), Phe259, Phe263 (TMS7), Asn292, Ser295, Arg299 (TMS8) or Phe378 and Ser382 (TMS11), had an active contribution to the interaction between the substrates and the transporter along their movement toward the cytoplasmic side of NmeA, as suggested by calculations. Importantly, specific residues in TMS1, TMS2, TMS4, TMS5, TMS7 and TMS11 have been shown to be critical for transport activity and substrates specificity in other MFS transporters (Soares-Silva et al., 2011; Madej et al., 2014; Heng et al., 2015; Kumar et al., 2015) . A graphical representation of the potential translocation pathway identified by docking calculations and the dominant binding site for uric acid at the transporter center are shown in Fig. 7 B-D. These simulations, together with analysis of conservation of primary sequence, provide useful guidelines for the rational design of genetic experiments as a mean to further explore the role of those residues in the NmeA substrate recognition and transport mechanism. In this direction, we noticed (observations not shown) that most of the amino acids identified herein, by docking, as putative substrate binding residues, are partly or highly conserved among A. nidulans NmeA homologues (see Fig. 1 ). Fully or highly conserved residues, such as the ones present in TMS8 (Asn292, Ser295 and Arg299) are very probably involved in a basic function related to transport catalysis or protein stability, rather than specificity, as the transporters sharing them seem to recognize different substrates (e.g. aspyridone or polyketides). In contrast all other residues in TMS1, TMS2, TMS4, TMS5, TMS7 and TMS11 might indeed have a role in determining substrate specificity in NmeA.
Discussion
This work identifies NmeA as a novel MFS efflux protein specific for exporting cytoplasmically accumulated toxic nucleobases/nucleosides and metals or metalloids. Thus, apparently the physiological function of NmeA is to increase the viability of A. nidulans, and evolutionary related fungi, under specific cytotoxic environmental conditions or from genetic lesions affecting purine or/ and metal homeostasis. Notably, NmeA proved to be specific for nucleobases and certain metals, but nonspecific for several other cytotoxic compounds and drugs tested. This work also highlights the use of AnMinos transposon as a unique tool for obtaining hypermorphic mutants via overexpression, and thus identifying novel gene functions. It would have been extremely unlikely NmeA to be discovered by other means.
All primary evidence presented in this work support that NmeA recognizes salvageable purines, xanthine, uric acid, allantoin and nucleobase/nucleoside-related drugs. By using modeling and docking approaches with two selected favorable substrates, uric acid and 5-fluorouridine, we confirmed the presence of a tentative single binding site for nucleobases/nucleosides, in the middle of NmeA structure, more or less similarly positioned with the substrate bonding site of all crystallized MFS transporters. We thus identified specific amino acids that might be involved in transporter function or critical for specificity, which open the way for a direct genetic analysis of structure-function relationships in NmeA.
Besides recognition of nucleobases or nucleosides, NmeA is also involved in metal or metalloid efflux. Interestingly, most currently known efflux transporters involved in metal toxicity are ABC-type transporters, belonging in the P-type ATPase (P-ATPase) family (3.A.3), the ATP-binding Cassette (ABC) Superfamily (3.A.1) or in the Resistance-Nodulation-Cell Division (RND) Superfamily (2.A.6). Moreover, most of these are found in prokaryotes. A distinct group of transporters also mediating metal tolerance, exemplified by Zrc1p/ Cot1p, are vacuolar carriers that provide zinc tolerance in S. cerevisiae by secreting this metal from the cytosol to the vacuole (Kamizono et al., 1989; MacDiarmid et al., 2000) . Zrc1p/Cot1p belong to the Cation Diffusion Facilitator (CDF) Family (2.A.4), which possesses six putative TMSs and is specific for cobalt, cadmium, zinc and possibly nickel, copper and mercuric ions (Kambe 2012) .
The involvement of NmeA in metal toxicity is more interesting. To our knowledge, only two other MFS transporters, both in S. cerevisiae, are known to be involved in tolerance to excess boron, namely Bor1p and Art1p. Bor1p is a plasma membrane protein that is homologous to the plant boron efflux transporters (Takano et al., 2007) . Atr1p, which is probably the main boron exporter in yeasts, is also required for resistance to aminotriazole and 4-nitroquinoline-N-oxide . It should be noted that although boron is essential for higher plants and is essential or beneficial for animals or fungi (Nielsen, 1997) , when present in excess is also toxic for most living organisms (Nable et al., 1997) . Owing to its toxicity to microorganisms, boron is also used as an antifungal agent (Sobel and Chaim, 1997) . A. nidulans and other Aspergilli have Bor1p and Art1p homologues, but these show low similarity (<38-50% identity) with the yeast transporters, so that, their specificity is probably different. Most importantly, unlike Bor1p and Atr1p or any other known MFS, NmeA is uniquely specific for boron, cadmium and zinc.
Cadmium is very toxic to most biological systems. A previous report suggested that CdCl 2 stimulates catalase (CAT), superoxide dismutase (SOD) and glutathione reductase (GR) activities and leads to the formation of reactive oxygen species inside the mycelia of A. nidulans (Guelfi et al., 2003) . Putative cadmiumexporting P-type ATPase activities might be present in A. oryzae and A. fumigatus, as the corresponding genes (AO090038000187 and Afu1g16130, respectively; http:// www.aspergillusgenome.org/) show significant similarity with Pca1p, a cadmium transporting P-type ATPase in some S. cerevisiae strains. A. nidulans and several other Aspergilli lack Pca1/AO090038000187/Afu1g16130 orthologues. In addition, all other A. nidulans transporters annotated as putative metal-specific carriers do not show any similarity to NmeA (observations not shown). The ubiquitous presence of NmeA in all Aspergilli and other Eurotiomycetes strongly suggests that this MFS exporter is the major detoxification exporter of cadmium. Unlike cadmium, Zinc is an essential element for sustaining all forms of life as over 300 enzymes employ zinc as their catalytic or structural component (Calera and Haas, 2008) . However, excess of zinc is also toxic for most living systems. All known zinc efflux proteins seem to be ABC-type transporters (http://www.tcdb.org/), making again NmeA the first MFS efflux protein identified that is involved in zinc detoxification.
The characterization of the specificity profile of NmeA suggests a possible metabolic interconnection of purine and metal homeostasis. This possibility has been supported previously in fungi and plants. More specifically, the toxic effect of Zn and Cu on Aspergillus niger and Penicillium citrinum growth has been reported to depend on physiological conditions related to nitrogen sources, and in particular, nitrate media provided reduced metal toxicity compared to ammonium-containing media (Sazanova et al., 2015) . These findings are compatible with the idea that ammonium represses purine catabolism and leads to depletion of purine metabolites, which in turn leads to reduced metal resistance. In Arabidopsis thaliana, Cd treatment leads to increased allantoin levels due to reduced allantoinase (ALN) gene expression and enzyme activity, and increased uricase (UO) transcripts (Nourimand and Todd, 2016) . Additionally, aln-3 loss-offunction mutants, which have elevated allantoin levels, show increased resistance to Cd, as they seem to contain less damaging superoxide radicals. The protective mechanism in aln-3 mutants involves enhanced activity of superoxide dismutase and ascorbate peroxidase, confirming that Cd causes oxidative stress (Nourimand and Todd, 2016) . Thus, the importance of purine breakdown to uric acid and ureides might also be related to scavenging of reactive ROS (Brychkova et al., 2008 , Takagi et al., 2016 Nourimand and Todd, 2016) . Other studies have further shown that various abiotic stresses activate allantoin and allantoate accumulation, conferring increased stress resistance to plants (Yesbergenova et al., 2005 , Alamillo et al., 2010 , Watanabe et al., 2014 , Irani and Todd, 2016 . Finally, there are also reports that show that certain nucleobases (Rodgers and Armentrout, 2004; Brandi-Blanco et al., 2009 ) and other metabolites, such as oxalic acid (Sazanova et al., 2015) or proline (Dinakar et al., 2008) chelate metals. In one case, metal chelation has been further shown to contribute to metal tolerance in fungi (Sazanova et al., 2015) . We think that it will be interesting to follow the relationship of metal tolerance to purine catabolism in A. nidulans, where several relevant mutations and other unique genetic tools for this purpose are available (Galanopoulou et al., 2014) .
Experimental procedures
Media, strains, standard genetic techniques and growth conditions
The A. nidulans strains used are shown in Supporting Information Table S1 . Standard complete (CM) and minimal media (MM) for A. nidulans growth were used. Media and supplemented auxotrophies were used at the concentrations given in http://www.fgsc.net. Urea or sodium nitrate was used as nitrogen sources at final concentrations of 5 mM or 10 mM, respectively. Nucleobases and analogues were used at the following final concentrations: 5-fluorouracil (5-FU) 100 lM, 5-fluorocytosine (5-FC) 100 lM, 5-fluorouridine (5-FUd) 10 lM, 8-azaguanine (8-azaG) 0.5 mM, oxypurinol (Oxyp) 100 lM, uric acid (UA) 2 mM and allantoin (All) 2 mM. CdCl 2 , ZnSO 4 and Na 2 B 4 O 7 were used at final concentration 100 lM, 0.5 mM and 0.5 mg ml
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, respectively. All media and chemical reagents were obtained from Sigma-Aldrich (Life Science Chemilab SA, Hellas) or AppliChem (Bioline Scientific SA, Hellas). Derivatives of mutant strains were obtained through genetic crosses based on auxotrophic markers for heterokaryon establishment and, then if needed, identified by relevant PCR. A. nidulans stains protoplast isolation and transformation was performed as described previously (Koukaki et al., 2003) . Selection of transformants was based on complementation of auxotrophies. Growth tests were performed at 378C for 2-3 days, at pH 6.8.
Standard nucleic acid manipulations and construction of plasmids and gene replacement cassettes
Genomic DNA and RNA extraction from A. nidulans was performed as described in http://www.fgsc.net. Plasmids, prepared in E. coli, and DNA restriction or PCR fragments were purified from agarose 1% gels with the Nucleospin Plasmid Kit or Nucleospin ExtractII kit, according to the manufacturer's instructions (Macherey-Nagel, Lab Supplies Scientific SA, Hellas). Northern blot analysis was performed as described in Sambrook et al. (1989) Information Table S2 . The vector used for overexpressing nmeA is a modified pGEM T-easy vector carrying a shorter version of the dehydrogenase of 3-phosphoglyceraldehyde gpdA constitutive promoter ($1000 bp), the trpC 3' termination region and the pantoB gene, as a selection marker (Krypotou et al., 2015a) . The nmeA ORF was obtained from wild-type genomic DNA by PCR using primers 1-2 and cloned at the SpeI-NotI sites of the vector. For the construction of an Nterminal GFP-tagged translational fusion of NmeA under the control of gpdA promoter, the relevant ORF lacking the translational stop codon (ORFns) was cloned together with gfp (pair of primers: 1-3 and 10-11) on the above vector. These constructs were used to transform strains auxotrophic for pantothenic acid (pantoB100). For the construction of nmeA null mutant, a linear DNA cassette containing 5 0 and 3 0 flanking sequences of the relevant ORF (AN2746) separated by a selection gene marker coding for orotidine-5'-phosphate-decarboxylase (AFpyrG, Afu2g036) of A. fumigatus was used to transform a strain, which, in addition, genetically lacks the nkuA DNA helicase (TNO2A7; Nayak et al., 2006) . The nmeAD deletion cassette was generated by sequential cloning of the relevant fragments (6) (7) (8) (9) into the pGEM T-Easy vector. Subsequently, the entire cassette, containing 5 0 UTR AN246 -AFpyrG -3 0 UTR AN246 , was amplified (primers 5-6) and used to transform the TNO2A7 strain, resulting in complementation of uracil/uridine auxotrophy (pyrG89). For the construction of a C-terminally GFP-tagged translational fusion of NmeA expressed under its native promoter, primers 1-10 were used to amplify ORFns AN246 -gfp from plasmid pGEMgpdA p -ORFns-gfp-trpC-pantoB, and the amplified fragment was cloned between the 5 0 UTR AN246 and 3 0 UTR AN246, present in a vector that also carries the pyrG selection marker. This plasmid was used to transform the TNO2A7 strain, based on complementation of the pyrG89 auxotrophy.
Membrane protein extraction and western blot analysis
Cultures for membrane protein extraction were grown in MM supplemented with urea at 378C for 8 h. Total protein extraction was performed as previously described (Galanopoulou et al., 2014) . Equal sample loading was estimated by Bradford assays. Total proteins (30 lg) were separated by SDS-PAGE (10% w/v polyacrylamide gel) and electroblotted (Mini PROTEAN TM Tetra Cell, BIORAD) onto PVDF membranes (Macherey-Nagel, Lab Supplies Scientific SA, Hellas) for immunodetection. The membrane was treated with 3% (w/v) BSA and immunodetection was performed with a primary mouse anti-GFP monoclonal antibody (Roche Diagnostics, Hellas), or a mouse anti-actin monoclonal (C4) antibody (MP Biomedicals Europe, Lab Supplies Scientific SA, Hellas) and a secondary goat antimouse IgG HRP-linked antibody (Cell Signaling Technology Inc, Bioline Scientific SA, Hellas). Blots were developed by the chemiluminescent method using the LumiSensor Chemiluminescent HRP Substrate kit (Genscript USA, Lab Supplies Scientific SA, Hellas) and SuperRX Fuji medical X-Ray films (FujiFILM Europe, Lab Supplies Scientific SA, Hellas).
Protein sequences and phylogenetic analysis
Aspergillus nidulans or other fungal protein sequences similar to NmeA were harvested using blastp from http://www. aspgd.org/ or https://www.ncbi.nlm.nih.gov/. Phylogenetic analysis was performed at http://www.phylogeny.fr/index.cgi using a likely-hood ratio software (Anisimova and Gascuel, 2006) .
Epifluorescence microscopy
Samples for inverted epifluorescence microscopy were prepared as previously described (Gournas et al., 2010; Karachaliou et al., 2013) . In brief, spore suspensions were allowed to germinate in sterile 35 mm l-dishes, high glass bottom (ibidi, Germany) in liquid MM supplemented with NaNO 3 as nitrogen source for 16-18 h at 258 and young mycelium was observed on an Axioplan Zeiss phase contrast epifluorescent microscope (AxioCam HR R3 camera) using the Zen lite 2012 software. The resulting images were acquired with a Zeiss-MRC5 digital camera using the AxioVs40 V4.40.0 software. Image processing, contrast adjustment and color vibrating were made using the Adobe Photoshop CS3 software. [H 3 ]-Xanthine (33.4 Ci/mmol, Moravek Biochemicals, CA, USA), [2,8-H 3 ]-Adenine (1.2 Ci/mmol, Moravek Biochemicals, CA, USA) or [5,6-H 3 ]-Uracil (1.2 Ci/mmol, Moravek Biochemicals, CA, USA) uptake in minimal media (MM) was assayed in A. nidulans conidiospores, germinating for 4 h at 378C, 140 rpm, concentrated at 10 7 conidiospores/ 100 lL after centrifugation and resuspension in fresh MM, pH 6.8, as recently described in Krypotou and Diallinas (2014) . All uptakes have been performed with mixtures of radiolabeled (1 lM) plus non-radiolabeled substrates (100 lM). For measuring steady state accumulations (Fig. 6 ) uptake assays were allowed to run for 30 min. Background uptake values were corrected by subtracting values obtained in the presence of 1000-fold excess unlabeled substrate. For estimating NmeA-mediated efflux, cells were allowed to accumulate radiolabeled substrates for 30 min, washed 3 times at 48C, resuspended in minimal media, and re-incubated at 378C for 30 min to allow potential efflux to proceed. Cells were then centrifuged, washed three times at 48C, and the remaining radioactivity within the cells was measured. All transport and efflux assays were carried out in at least three independent experiments, with three replicates for each concentration or time point. Standard deviation was <20%. GraphPad Prism software (http://www. graphpad.com/scientific-software/prism/) was used to analyze the results.
Transport and efflux assays

Homology modeling of NmeA and substrate docking calculations
A theoretical model of NmeA was created, aiming to shed light on the events and structural determinants related to substrate recognition. A query for the most suitable structural template for NmeA was performed by utilizing the HHpred algorithm (https://toolkit.tuebingen.mpg.de/hhpred) against proteins with a known three-dimensional structure. An excellent homology score was obtained with the cytoplasm-facing structure of the Glycerol-3-phosphate transporter (GlpT; PDB code: 1PW4) of Escherichia coli (Probability 5 100.00, E-value 5 4.7e 243 , Score 5 337.64), despite the low primary amino acid similarity (identity 15%). Several other MFS crystal structures also afforded good scores, yet significantly lower than the one obtained for GlpT (Huang et al., 2003) . The NmeA-GlpT alignment was created on the basis of the HHpred results and a three-dimensional model of NmeA was subsequently built using the web version of MODELLER software (Sali et al., 1995) (https://toolkit.tuebingen.mpg.de/modeller). Validation of the derived homology model was performed by 30 ns MD run implementing Desmond software running on GPU (D.E. Shaw Research). The protein was solvated by the TIP3P solvent model and embedded in a POPC membrane bilayer, with the membrane coordinates recovered by the OMP server (http:// opm.phar.umich.edu/). The system was neutralized accordingly by counter ions and the total ionic strength was adjusted to 0.15M using NaCl. System equilibration was performed by the specific membrane protein relaxation protocol provided by Desmond and production simulation was performed at 300K using the NPgT ensemble (surface tension of 4000 barÁÅ ). Stability of the model was evident in the corresponding metrics such as RMS deviation of TMS alpha carbons from starting coordinates not exceeding 3 Å . The recognition by NmeA of substrates such as uric acid and 5-fluorouridine was studied by implementing a highly efficient flexible docking protocol utilizing 10K steps of mixed Monte-Carlo/Low Mode sampling (MacroModel module in Schr€ odinger Suite 2015). The specific protocol utilizes both a stochastic and a deterministic sampling component in a 1:1 ratio and is thus considered highly efficient in accounting for protein structural rearrangements upon ligand binding and overcoming rigid docking artifacts. It has been implemented in the past for similar systems, affording consistent results (Soares-Silva et al, 2011) . The OPLS2005 force field, the truncated Newton minimization algorithm, a ligand translation cutoff of 8 Å and a surface Generalized Born implicit solvent model were used for docking calculations.
Uric acid and allantoin determination by HPLC
The strains used for the evaluation of uric acid or allantoin export levels expressed (either in a standard wild-type strain or in uaZ14 or alxD mutant background) NmeA from its endogenous promoter or from gpdAp, or contained a total deletion of the nmeA gene. Loss-of-function mutants uaZ14 and alxD, when grown in the presence of purines, accumulate cytotoxic concentrations of uric acid and allantoin due to genetic mutations in the genes encoding uric acid oxidase or allantoinase, respectively (Galanopoulou et al., 2014) . Cultures of the above strains were grown for 16 h at 378C in liquid MM, plus 10 mM NaNO 3 as nitrogen source and necessary supplements, before 1 mM adenine was added and growth was allowed to continue for 16 more h. Supernatants from these cultures were collected (4000 rpm, 15 min), filtered through 0.22 lm Millipore filters and transferred to new tubes for further analysis. For the determination of uric acid or allantoin concentration in these supernatants, a methodology based on a combination of relevant published HPLC protocols was employed (Mei et al.,1996; Fu et al., 2006) . Briefly, the products of the filtered samples were introduced through a 10 ll injection loop into a Discovery (R) BIO Wide Pore C18-5 column (5 lm) 250 3 4.6 mm (Sigma -Aldrich) mount on a 1090 Series II HPLC system (Hewlett-Packard Co.) equipped with a Hitachi LaChrom L-7100 pump system and an HP 1046A variable UV detector. Separation was achieved isocratically using a 20 mM KH 2 PO 4 buffer at pH 3 and a flow rate of 1 ml/min. Uric acid and allantoin were determined at 292 and 205 nm, respectively. Peak identity and validation was confirmed by comparison to the elution time of known uric acid or allantoin standards in combination with matrixspike analysis on most of the samples (especially for allantoin). Quantification was performed through a calibration curve that correlated the concentration of the uric acid or allantoin standards to the corresponding peak areas.
